Artur Prusaczyk
Overview
Explore the profile of Artur Prusaczyk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nowakowski A, Prusaczyk A, Szenborn L, Ludwikowska K, Paradowska-Stankiewicz I, Machalek D, et al.
Acta Dermatovenerol Alp Pannonica Adriat
. 2024 Dec;
33(4):189-197.
PMID: 39707894
This review assesses Poland's activities in preventing and managing human papillomavirus (HPV)-related diseases, summarizing information from the 2023 HPV Prevention and Control Board meeting. Progress in primary, secondary, and tertiary...
2.
Matuszczak M, Kiljanczyk A, Marciniak W, Derkacz R, Stempa K, Baszuk P, et al.
Hered Cancer Clin Pract
. 2024 Sep;
22(1):19.
PMID: 39300540
Objective: To investigate whether Molybdenum blood level is a marker of cancer risk on BRCA1 carriers. Methods: A prospective cohort study was conducted among 989 initially unaffected women with a...
3.
Matuszczak M, Kiljanczyk A, Marciniak W, Derkacz R, Stempa K, Baszuk P, et al.
Antioxidants (Basel)
. 2024 Jul;
13(7).
PMID: 39061909
Pathogenic mutations in BRCA1 (BReast CAncer gene 1) confer high risks of both breast (up to 70%) and ovarian (up to 40%) cancers. Zinc (Zn) and copper (Cu) are essential...
4.
Kiljanczyk A, Matuszczak M, Marciniak W, Derkacz R, Stempa K, Baszuk P, et al.
Nutrients
. 2024 Jun;
16(11).
PMID: 38892720
Breast cancer and ovarian cancer pose a significant risk for BRCA1 carriers, with limited risk-reduction strategies. While improved screening helps in the early detection of breast cancer, preventive measures remain...
5.
Matuszczak M, Kiljanczyk A, Marciniak W, Derkacz R, Stempa K, Baszuk P, et al.
Antioxidants (Basel)
. 2024 May;
13(5).
PMID: 38790714
BRCA1 mutations predispose women to breast and ovarian cancer. The anticancer effect of zinc is typically linked to its antioxidant abilities and protecting cells against oxidative stress. Zinc regulates key...
6.
Kiljanczyk A, Matuszczak M, Marciniak W, Derkacz R, Stempa K, Baszuk P, et al.
Nutrients
. 2024 May;
16(9).
PMID: 38732616
BRCA1 mutations substantially elevate the risks of breast and ovarian cancer. Various modifiers, including environmental factors, can influence cancer risk. Lead, a known carcinogen, has been associated with various cancers,...
7.
Norek I, Prusaczyk A, Piatek S, Bidzinski M, Nitsch-Osuch A, Bogdan M
Ginekol Pol
. 2023 Oct;
PMID: 37842990
Objectives: Assessment of the development and description of the characteristics of social marketing in Poland and the United States with regard to the prevention of gynecological cancers and achievements of...
8.
Prusaczyk A, Gujski M, Onyskow W, Zuk P, Warsz L, Nitsch-Osuch A, et al.
Med Sci Monit
. 2023 Aug;
29:e939169.
PMID: 37553822
BACKGROUND The health sector in Poland is currently facing challenges such as limited financial resources, poor infrastructure, and insufficient human resources. To address these issues, increasing cost-effectiveness at the individual...
9.
Prusaczyk A, Bogdan M, Vinker S, Gujski M, Zuk P, Kowalska-Bobko I, et al.
Int J Environ Res Public Health
. 2023 Mar;
20(5).
PMID: 36900836
Background: Poland is witnessing a migration crisis caused by the ongoing military conflict in Ukraine. In addition to housing and necessities, 1.8 million Ukrainians that had taken refuge in Poland...
10.
Piatek S, Urbanski F, Karczmarz S, Prusaczyk A, Sobiczewski P, Bogdan M, et al.
Med Sci Monit
. 2023 Jan;
29:e938776.
PMID: 36650732
BACKGROUND Surgery is a cornerstone in management of ovarian and endometrial cancer. The European Society of Gynecological Oncology introduced quality indicators to improve management of these cancers. The optimal annual...